Saturday, September 5, 2026
ExploreSearch
Via News
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· May 26, 2026

Beat the Market the Zacks Way: ORIX, Starbucks, Alphabet in Focus

View original at finance.yahoo.com
Beat the Market the Zacks Way: ORIX, Starbucks, Alphabet in Focus Last week, major U.S…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.

    60% confidence

  • Legacy Housing Corporation, upgraded to Zacks Rank #2 on March 19, has returned 18% versus the S&P 500's 13% increase since then.

    60% confidence

  • A portfolio of Zacks #1 Rank (Strong Buy) stocks has outperformed the S&P 500 index by almost 8 percentage points year-to-date through May 5, returning +13.14% versus +5.19% for the S&P 500 and +7.76% for the equal-weight version.

    60% confidence

  • Federal Reserve policymakers were still concerned about inflation pressures from higher energy costs and global conflicts.

    60% confidence

  • Shares of ORIX Corporation have gained 30.3% (versus the S&P 500's 14.2% increase) since it was upgraded to a Zacks Rank #2 (Buy) on March 25.

    60% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Capital Surge Meets Investor Caution: Record Funding Rounds and Government Contracts Amid Valuation Skepticism
A single-week cluster of large AI/fintech funding rounds (Socure, Stability AI, Emerald AI, Generalist AI, Instinct, Gatik, Regent Craft) shows venture capital still pouring into AI infrastructure, identity, and autonomy plays, while Palantir's Army TITAN contract win coincided with a 6% stock drop — signaling that even flagship AI-defense revenue isn't immune to market reassessment of AI valuations. Efficiency-focused innovations like Multiverse Computing's model compression suggest the sector is also pivoting toward cost/inference economics as capital intensity draws scrutiny.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Morgan Stanley & Co. LLC
The same metric (eps) for the same entity (Morgan Stanley & Co. LLC) reported for the identical fiscal period (Q1 2026) and observation date (2026-03-31) has two conflicting values: 3.43 USD_per_share vs 3.08 USD. This is not a temporal change — both observations claim to measure the same point in time. The ~10% discrepancy (0.35 USD difference) is material for a financial metric.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,273 source documents archived
Query this data → isubstrate.com
Beat the Market the Zacks Way: ORIX, Starbucks, Alphabet in Focus — Source | Via News | Via News